Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Amortization - Intangibles (2019 - 2024)

Historic Amortization - Intangibles for Akebia Therapeutics (AKBA) over the last 6 years, with Q4 2024 value amounting to $9.0 million.

  • Akebia Therapeutics' Amortization - Intangibles changed 0.0% to $9.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 7500.21%. This contributed to the annual value of $36.0 million for FY2024, which is 0.0% changed from last year.
  • Per Akebia Therapeutics' latest filing, its Amortization - Intangibles stood at $9.0 million for Q4 2024, which was down 0.0% from $9.0 million recorded in Q3 2024.
  • Akebia Therapeutics' Amortization - Intangibles' 5-year high stood at $9.1 million during Q2 2020, with a 5-year trough of $6.1 million in Q3 2020.
  • Over the past 5 years, Akebia Therapeutics' median Amortization - Intangibles value was $9.0 million (recorded in 2021), while the average stood at $8.8 million.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first plummeted by 3290.85% in 2020, then skyrocketed by 4757.62% in 2021.
  • Over the past 5 years, Akebia Therapeutics' Amortization - Intangibles (Quarter) stood at $8.3 million in 2020, then increased by 8.42% to $9.0 million in 2021, then changed by 0.0% to $9.0 million in 2022, then changed by 0.0% to $9.0 million in 2023, then changed by 0.0% to $9.0 million in 2024.
  • Its Amortization - Intangibles stands at $9.0 million for Q4 2024, versus $9.0 million for Q3 2024 and $9.0 million for Q2 2024.